What Underlies the Benefit of Famotidine Formulations Used During COVID-19?

Gastroenterology. 2021 Apr;160(5):1899-1900. doi: 10.1053/j.gastro.2020.07.051. Epub 2020 Aug 7.

Authors

Vijay P Singh¹, Bara El-Kurdi², Christopher Rood³

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona.
² Department of Gastroenterology, University of Texas San Antonio, San Antonio, Texas.
³ Saint Louis University School of Medicine, Saint Louis, Missouri.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Famotidine*
Humans
Propensity Score
Retrospective Studies
SARS-CoV-2

Substances

Famotidine